Cell Therapeutics Inc. (CTIC) Posts Q4 Loss of 9c/Share
Tweet
Share
E-mailGet Alerts CTIC Hot Sheet
Price: $9.09 --0%
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
Noncontrolling interest: 178K
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Cell Therapeutics Inc. (NASDAQ: CTIC) reported Q4 EPS of ($0.09), $0.01 worse than the analyst estimate of ($0.08).
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
For earnings history and earnings-related data on Cell Therapeutics Inc. (CTIC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stitch Fix (SFIX) Tops Q4 EPS by 4c; Offers Guidance
- Alcoa closes $2.6B debt offering to fund South32 asset acquisition
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
